DARE Dare Bioscience Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: DARE

Price (delayed)

$0.8074

Market cap

$12.34M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.71

Enterprise value

$744,889

?
Relative Growth: Rel. Growth: 64
Relative Strength: Rel. Strength: 3
Relative Valuation: Rel. Valuation: 9
Relative Profitability: Rel. Profitability: 17
Highlights
DARE's EPS has surged by 67% year-on-year and by 26% since the previous quarter
The debt has dropped by 66% year-on-year and by 37% since the previous quarter
The company's quick ratio has surged by 185% YoY but it fell by 15% QoQ
The equity has plunged by 176% from the previous quarter but it has soared by 96% YoY
The company's gross margin fell by 30% QoQ
The company's gross profit fell by 18% QoQ
Sector: Healthcare
Industry: Biotechnology
Website: http://www.darebioscience.com
Peers: OLMA OMER

Key stats

What are the main financial stats of DARE

DARE stock price

How has the Dare Bioscience stock price performed over time
Intraday
-5.01%
1 week
11.29%
1 month
-1.52%
1 year
-60.81%
YTD
-58.17%
QTD
-61.73%

Financial performance

How have Dare Bioscience's revenue and profit performed over time
Revenue
$1.37M
Gross profit
$507,926
Operating income
-$11.11M
Net income
-$10.99M
Gross margin
37.2%
Net margin
-804.4%
DARE's net income is up by 41% year-on-year and by 9% since the previous quarter
The company's operating income rose by 40% YoY and by 7% QoQ
The company's gross margin fell by 30% QoQ
The net margin rose by 23% since the previous quarter

Price vs fundamentals

How does DARE's price correlate with its fundamentals

Growth

What is Dare Bioscience's growth rate over time

Valuation

What is Dare Bioscience stock price valuation
P/E
N/A
P/B
N/A
P/S
8.8
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.55
DARE's EPS has surged by 67% year-on-year and by 26% since the previous quarter
The equity has plunged by 176% from the previous quarter but it has soared by 96% YoY
DARE's revenue is up by 18% QoQ

Efficiency

How efficient is Dare Bioscience business performance
The ROA has soared by 63% YoY and by 16% from the previous quarter
DARE's return on sales is up by 23% since the previous quarter

Dividends

What is DARE's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for DARE.

Financial health

How did Dare Bioscience financials performed over time
The total assets is 2.4% less than the total liabilities
The current ratio has soared by 191% YoY but it has contracted by 3.9% from the previous quarter
The company's quick ratio has surged by 185% YoY but it fell by 15% QoQ
The debt to equity has plunged by 183% from the previous quarter
The equity has plunged by 176% from the previous quarter but it has soared by 96% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.